Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade

BACKGROUND: Though immune checkpoint blockade (ICB) against PD-1 has shown success in the treatment of lung cancer, not all patients respond. We have previously shown that adoptive transfer of double negative T (DNT) cells expanded from healthy donors can target leukemia but their role in treating e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Fang, Linan, Ly, Dalam, Wang, Si-si, Lee, Jong Bok, Kang, Hyeonjeong, Xu, Hao, Yao, Junlin, Tsao, Ming-sound, Liu, Wei, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413451/
https://ncbi.nlm.nih.gov/pubmed/30857561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1126-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados